OnkoSight Advanced Chronic Lymphoid Neoplasma NGS OSACLN

Synonyms

CLL Cancer NGS Panel

Allscripts (AEHR) Order Name

OnkoSight Advanced Chronic Lymphoid Neoplasma NGS

Sunrise Clinical Manager (SCM) Order Name

OnkoSight Advanced Chronic Lymphoid Neoplasma N

EPIC Order Name

OnkoSight Advanced Chronic Lymphoid Neoplasm

Clinical Info

This test includes the following genes: ARID1A, ATM, B2M, BCL2, BIRC3, BRAF, BTK, CARD11, CCND1, CCND3,
CD79B, CDKN2A, CREBBP, CXCR4, DNMT3A, EP300, EZH2, FBXW7, FOXO1, IDH2, IRF4, JAK1, JAK3, KRAS, 
MAP2K1, MAPK1, MEF2B, MYC, MYD88, NOTCH1, NOTCH2, NRAS, NSD2, PIK3CD, PIM1, PLCG2, PRDM1, 
RHOA, SETD2, SF3B1, SOCS1, STAT3, STAT5B, STAT6, TCF3, TET2, TNFAIP3, TNFRSF14, TP53 and XPO1.

Specimen Type

Blood, Bone Marrow

Specimen Volume

Volume
3-5 mL (blood), 1-2 mL (bone marrow)
Minimum Volume
3 mL (blood), 1 mL (bone marrow)

Container

Lavender Top Tube

Collection Instructions

Container
Lavender-top (EDTA) tube; green-top (sodium heparin) tube; cells left over from flow cytometry analysis,
either fresh cell suspension or fresh/frozen cell pellet spun down from suspension.
Cell suspension should be shipped on ice.
Causes for Rejection
Specimen does not meet criteria for sample type, container, minimum volume, collection and storage; frozen whole blood 
or marrow; leaking tube; clotted blood or marrow; grossly hemolyzed specimen or otherwise visibly degraded; contaminated 
specimen; contains suspicious foreign material

Transport Instructions

Room Temperature

Specimen Stability

Methodology

The Labcorp Myeloid NGS assay utilizes capture-based next generation sequencing of whole genomic DNA libraries
to identify gene alterations that have diagnostic, prognostic and therapeutic significance in lymphoid malignancies.

Days Performed

TAT: 10-14 Days

Performing Laboratory

Labcorp

CPT

81450

PDM

235442

Result Interpretation

Forms